Erleada (apalutamide)

pCPA File Number: 21081
Negotiation Status:
Concluded with an LOI
Indication(s):
Non-metastatic Castration-resistant prostate cancer
Sponsor/Manufacturer:
Janssen Inc.
CDA-AMC Project Number:
PC0133-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: